Top Rated Report: Indian Personal Hygiene Market - 2017

This report is an assessment of the Indian Personal Hygiene market, within the context of the personal care industry, and the opportunities and challenges it presents. It analyses the diverse segments of the industry and the dynamics that propel it.

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/indian-personal-hygiene-market-2017

The opportunities, competition, infrastructure investment and regulatory policies that govern the sector are also examined in the report. The personal hygiene segment in India is witnessing a trend of premiumization, primarily in the urban market segment. 

Consumers are more inclined towards buying the best available products. This up-trading in personal care was a predicted phenomenon given the contemporary reach of media and emphasis on grooming.

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170703

Table of Content

Executive Summary

1. Overview

1.1 Indian Personal Care Market 

1.2 Indian Personal Hygiene Market 

2. Product Consumption Pattern

2.1 Consumption in Rural & Urban Areas 

Contact

M/s  Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/

New Research Report:- EpiCast Report: Pancreatic Cancer

Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries (Michaud, 2004). Pancreatic cancer originates from transformed cells from tissues within the exocrine component of the pancreas. The most common type is adenocarcinoma associated with the exocrine gland (ACS, 2013). The pancreas is found deep within the body, leading to the inability to detect pancreatic cancer early-on. Most cases of pancreatic cancer go undetected from the lack of obvious symptoms, causing the cancer to spread to other organs.

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/epicast-report-pancreatic-cancer-epidemiology-forecast-to-2022

GlobalData forecasts that the US and Germany will have the highest number of incident cases of pancreatic cancer in 2022. GlobalData epidemiologists also expect that the number of prevalent cases of pancreatic cancer in the 6MM covered will increase during the forecast period (2012–2022) to a total of 59,675 cases. The stage at diagnosis for pancreatic cancer is correlated with the availability of screening tests and the ability to identify early symptoms. Due to the inability to identify early indications of the illness, pancreatic cancer cases are most commonly diagnosed in Stage IV. Greater research in prevention and early diagnostic testing can help reduce the incidence of the disease. Through early detection, it may be possible to stop the spread of the cancer to other organs and decrease the overall mortality.

Scope

The Pancreatic Cancer EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of pancreatic cancer in the six major markets (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of the incident cases of pancreatic cancer segmented by sex, age (in five-year increments beginning at 15 years and ending at ages 85 years and older), stage at diagnosis, the proportion of incident cases that undergo resection, locally-advanced unresectable cases, metastatic cases, and biomarker mutation type (KRAS and HER2) in these markets, along with the prevalent cases.

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170705

Reasons To Buy

·         Develop business strategies by understanding the trends shaping and driving the global pancreatic cancer market.

·         Quantify patient populations in the global pancreatic cancer market to improve product design, pricing, and launch plans.

·         Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for pancreatic cancer treatment in each of the markets covered.

·         Identify patients based on stage at diagnosis, the proportion of incident cases that undergo resection, locally-advanced unresectable cases, metastatic cases, and biomarker mutation type (KRAS and HER2) in these markets covered.

Contact

M/s  Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/

Top Viewed Report:- MediPoint: Total Shoulder Replacement

Compared with the more mature reconstruction markets, such as hip and knee replacements, shoulder reconstruction is developing as a specialty. Current market growth in shoulder reconstruction is mainly driven by total shoulder replacement (TSR), which comprises anatomic total and reverse total shoulder replacements. Although sluggish economic growth has hindered the large-joint replacement market in the United States and Europe, the global TSR market has seen a promising growth rate in the past few years. 

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/medipoint-total-shoulder-replacement-global-analysis-and-market-forecasts

This healthy growth can be attributed to an increasing patient population, an improved surgeon adoption of reverse shoulder implants, as well as evolving insurance and reimbursement landscape. This report focuses on TSR market in 10 countries: the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. GlobalData evaluated currently marketed TSR prostheses, identified the unmet needs in the market, and provided an understanding of surgeon perception of the latest advances within the shoulder community. 

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170704

Over the forecast period, despite the dampening effect of downward pricing pressure, the TSR market is expected to enjoy healthy growth, primarily driven by the trend of active aging, continuous medical education efforts from the supply side, the introduction of additional reverse shoulder implants and the FDA’s approval of modern stemless designs. In particular, the market size of reverse TSR is expected to grow at a much faster pace compared with anatomic TSR. 

Contact

M/s  Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/

Study Report: Industrial Construction in Malaysia to 2016

Timetric’s 'Industrial Construction in Malaysia to 2016: Market Forecast' contains detailed historic and forecast market value data for the industrial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods.

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/industrial-construction-in-malaysia-to-2016-market-forecast

Summary

This report is the result of Timetric’s extensive market research covering the industrial construction industry in Malaysia. It contains detailed historic and forecast market value data for the industrial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Industrial Construction in Malaysia to 2016: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the industrial construction industry in Malaysia. It is an essential tool for companies active across the Malaysian construction value chain and for new players considering to enter the market.

Scope

• Overview of the industrial construction industry in Malaysia
• Historic and forecast market value for the industrial construction industry by construction output and value-add methods for the period 2007 through to 2016
• Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the industrial construction industry for the period 2007 through to 2016

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170320

Reasons To Buy

• This report provides you with valuable data for the industrial construction industry in Malaysia
• This report provides you with a breakdown of market value by type of construction activity (new construction, repair and maintenance, refurbishment and demolition)
• This report enhances your knowledge of the market with key figures detailing market values using the construction output and value add methods
• This report allows you to plan future business decisions using the forecast figures given for the market

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/

Global Pharma Report: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022

GlobalData has released its new Country report, PharmaPoint: Meningococcal Vaccines Australia Drug Forecast and Market Analysis to 2022. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines. Currently, tetravalent conjugate vaccines, such as Sanofis Menactra and Novartis Menveo, account for the vast majority of global sales, with the US adolescent market being the key target segment. GlobalData expects growth in the meningococcal vaccines market to be primarily driven by the launch of serotype B vaccines, which address a critical unmet need in the treatment landscape. Vaccines that better protect infants and/or provide a longer duration of immunity also have an opportunity to seize market share during 2012-2022.

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/pharmapoint-meningococcal-vaccines-australia-drug-forecast-and-market-analysis-to-2022

GlobalData believes that relative patient share for the three MenC conjugate vaccines available in Australia will remain unchanged for the duration of the forecast period because Nuron Biotechs Meningitec, Novartis Menjugate, and Baxters NeisVac-C possess nearly identical clinical profiles and price points. The MenC conjugate patient share is largely determined by prescriber preference in Australia and therefore is not expected to change drastically during the forecast period.

Scope

• Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
• Detailed information on the key drugs in Australia including product description, safety and efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in Australia from 2012-2022.
• Analysis of the impact of key events as well the drivers and restraints affecting Australia Meningococcal Vaccines market.

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170317

Reasons to buy

• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of drug performance
• Obtain sales forecast for drugs from 2012-2022 in Australia

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/

Global Pharma: Meningococcal Vaccines - United Kingdom Drug Forecast and Market Analysis to 2022

GlobalData has released its new Country report, PharmaPoint: Meningococcal Vaccines United Kingdom Drug Forecast and Market Analysis to 2022. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines. Currently, tetravalent conjugate vaccines, such as Sanofis Menactra and Novartis Menveo, account for the vast majority of global sales, with the US adolescent market being the key target segment. GlobalData expects growth in the meningococcal vaccines market to be primarily driven by the launch of serotype B vaccines, which address a critical unmet need in the treatment landscape. Vaccines that better protect infants and/or provide a longer duration of immunity also have an opportunity to seize market share during 2012-2022.

To Read The Complete Report with  TOC :-

http://www.marketresearchreports.biz/analysis-details/pharmapoint-meningococcal-vaccines-united-kingdom-drug-forecast-and-market-analysis-to-2022

GlobalData predicts that relative patient share for the three MenC conjugate vaccines will shift due to changes being made to the UK MenC schedule (DOH, 2013b). Meningitec will lose sales due to its elimination from the single primary dose, with patient share expected to be made up by Menjugate and NeisVac-C.

Scope

• Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
• Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in the UK from 2012-2022.
• Analysis of the impact of key events as well the drivers and restraints affecting the UK Meningococcal Vaccines market.

To Buy a Copy Of This Report:-

http://www.marketresearchreports.biz/analysis/170316

Reasons to buy

• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of drug performance
• Obtain sales forecast for drugs from 2012-2022 in the UK

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog:  http://marketsbuzz.wordpress.com/